Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS) The purpose of this study is to determine the Maximum Tolerated Dose, Dose Limiting Toxicities and optimal dosing schedule of 4SC-202 investigating its safety, tolerability and pharmacokin...

• Pays Germany
• Organes Aucun
• Spécialités Aucune

EMMA-1 (Erbitux for Multiple Myeloma) EMMA-1 is an open-label, non-randomized, two-stage phase II study. Patients with refractory multiple myeloma stage II or III or relapsed disease after at least one line of treatment will r...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune